Press releases dating back to 2009 are available below. Search them by keyword or browse by year/business category. Press releases for our local operating companies can be viewed on our country websites.
ViiV Healthcare presents positive, 48-week data from two pivotal phase III studies showing long-acting, injectable two-drug regimen of cabotegravir and rilpivirine has similar efficacy to daily, three-drug oral treatment in adults living with HIV-1 infection
Comprehensive data from ATLAS and FLAIR studies presented today at the 2019 Conference on Retroviruses and Opportunistic Infections show investigational long-acting injectable t...Read more
GSK receives a positive CHMP opinion for intravenous zanamivir for the treatment of complicated influenza
GSK today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for intravenous zanamivir...Read more
GSK Science in the Summer™ unveils 2019 curriculum: The Science of Me
Free STEM program in partnership with The Franklin Institute to reach 26,000 students nationwide this year.Read more
Find out more about us
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
We make a wide range of prescription medicines, vaccines and consumer healthcare products.
Science can improve health and well-being in so many ways, from the development of everyday convenience healthcare products through to life-saving medicines and vaccines